In her debut blog, Emma Wallace explores a recent US cross-sectional study, which suggests an exclusive focus on the mental health antecedents of suicide will exclude around 20% of people who attempt to take their own lives.
[read the full story...]
Ana Veic considers clinician’s perspectives of the benefits of physical exercise in treatment for post-traumatic stress disorder and complex trauma.
[read the full story...]
Rena Gatzounis summarises a review investigating the effectiveness of digital interventions for eating disorders and the behaviour change techniques that lie underneath.
[read the full story...]
Amanda Sabo and Louise La Sala summarise a recent review investigating the impact of social media use on internalising symptoms in adolescents from clinical and community samples.
[read the full story...]
Jack Wainwright explores how ADHD can impact on all aspects of our lives, not just the three key symptom domains, but on our lifestyle, physical and mental health.
[read the full story...]
Kalya Win Aung, Angela Kibia and Dorothy Williams consider a systematic review and network meta-analysis published by the Lancet Psychiatry on psychological and psychosocial interventions for treatment-resistant schizophrenia.
[read the full story...]
Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.
[read the full story...]
Magenta Simmons and Belle Boland consider an umbrella review on the effectiveness and implementation of peer support interventions in mental health.
[read the full story...]
Shuichi Suetani blogs a new study published today in The Lancet Psychiatry, which suggests that those patients who might benefit most from evidence-based guidance are the least represented in clinical trials about ADHD medication. Is it time to reconsider the value we place on RCTs when they do not include the vast majority of people who need help?
[read the full story...]
David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]
